Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Jan 03, 2012 Nature speaks with Keim about H5N1 studies -
-
-
Jun 20, 2011 Promising skin-cancer drug nears approval
Share on Twitter
Share on Facebook
Email to a friend
Print Article
Michigan's Van Andel Institute set to open expanded facility, triple staff
[Source: GenomeWeb News] – Van Andel Institute next week will formally open its $178 million Phase II research-education project, an expansion of its Grand Rapids, Mich., facility that will nearly triple its laboratory space, allowing it to expand its research and more than triple its staff.
The institute will mark the project's completion with a Dec. 8 ribbon-cutting. Van Andel will use the eight-story, 240,000-square-foot Phase II facility to house expanded research space for neurological disorders such as Parkinson's disease, Alzheimer's disease, ALS, and multiple sclerosis, in addition to chronic illnesses such as diabetes through an affiliation with the Translational Genomics Research Institute in Phoenix.
For more information: Van Andel Set to Open Expanded Facility, Triple Staff
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
